Alpheus Medical Funding: $80M Raised, Series B (2025)
Alpheus Medical is a Biotech company based in Chanhassen/Oakdale, Minnesota. It has raised $80M in total funding. Latest round: Series B.
Alpheus Medical funding overview
Alpheus Medical is a Biotech company based in Chanhassen/Oakdale, Minnesota. Alpheus Medical has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2025. The round record for Alpheus Medical runs through 2025; nothing later has been disclosed. Investors on record include HealthQuest Capital, Samsara BioCapital, American Cancer Society. 3 distinct backers are named across the disclosed rounds.
Alpheus Medical at a glance
Total raised
$80M
Latest round
Series B
Latest round date
May 2025
Industry
Biotech
Headquarters
Chanhassen/Oakdale, Minnesota
Notable investors
HealthQuest Capital, Samsara BioCapital, American Cancer Society
Frequently asked about Alpheus Medical funding
How much has Alpheus Medical raised?
Alpheus Medical has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Alpheus Medical?
HealthQuest Capital, Samsara BioCapital, American Cancer Society are named among the investors backing Alpheus Medical.
What was the latest Alpheus Medical funding round?
The most recent disclosed round is a Series B, announced in May 2025.
Where is Alpheus Medical based?
Alpheus Medical is based in Chanhassen/Oakdale, Minnesota.
What sector does Alpheus Medical operate in?
Alpheus Medical is tracked under Biotech from Chanhassen/Oakdale, Minnesota, with $80M in disclosed funding.
When did Alpheus Medical last raise?
The last disclosed Alpheus Medical round closed in May 2025 at Series B.
We update the Alpheus Medical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Chanhassen/Oakdale and their backers are listed below.
